Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8063084

Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid le

Xenon Pharmaceuticals Inc. · Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8062643

Use of neurotoxin therapy for treatment of urologic and related disorders

The Regents of the University of Colorado · Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8058268

Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

Lixte Biotechnology, Inc. · Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8057807

Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044033

Fluorocytidine derivatives and COX-2 inhibitors for the treatment of cancer

The Board of Regents of the University of Texas System · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8043623

Immunogenic peptides for the treatment of prostate and breast cancer

The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039001

Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus in

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8034768

Composition and method for the treatment of diseases affected by histone deacetylase inhib

The Board of Regents of the University of Texas System · Granted Tue Oct 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8029826

Chlorite in the treatment of neurodegenerative disease

The Regents of the University of California · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8030297

Controlled release corticosteroid compositions and methods for the treatment of OTIC disor

The Regents of the University of California · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8029808

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment mo

UNIVERSITY OF CONNECTICUT · Granted Tue Oct 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8025891

Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamy

The Regents of the University of California · Granted Tue Sep 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8003685

Thiophene analogues for the treatment or prevention of flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated · Granted Tue Aug 23 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998928

Method of treatment of type-1 diabetes with a humanin analogue

The Regents of the University of California · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998684

Screening method for an agent for treatment of neurodegenerative disease

Takeda Pharmaceutical Company Limited · Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7993865

Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen

The Regents of the University of California · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994178

Crystalline rosuvastatin calcium and compositions thereof for treatment of hyperlipidaemia

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994166

Pyrrolidinone benzenesulfonamide derivatives as modulators of ion channels for the treatme

Vertex Pharmaceuticals Incorporated · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7994132

Peptides for treatment of scleroderma

The Regents of the University of California · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7993866

Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen

The Regents of the University of California · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7993867

Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen

The Regents of the University of California · Granted Tue Aug 09 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7985769

Compounds and methods for the treatment or prevention of Flavivirus infections

Vertex Pharmaceuticals Incorporated · Granted Tue Jul 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7972793

Methods and compositions for the treatment of psychotic disorders through the identificati

SureGene LLC · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968511

Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted